KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Gross Profit (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Gross Profit for 9 consecutive years, with $589.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 13.49% to $589.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Dec 2025, up 6.44% year-over-year, with the annual reading at $2.6 billion for FY2025, 6.44% up from the prior year.
  • Gross Profit hit $589.0 million in Q4 2025 for Elanco Animal Health, down from $607.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $763.0 million in Q1 2023 to a low of $519.0 million in Q4 2023.
  • Historically, Gross Profit has averaged $632.4 million across 5 years, with a median of $626.0 million in 2021.
  • Biggest five-year swings in Gross Profit: skyrocketed 150.69% in 2021 and later decreased 11.92% in 2022.
  • Year by year, Gross Profit stood at $602.0 million in 2021, then decreased by 10.8% to $537.0 million in 2022, then fell by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then grew by 13.49% to $589.0 million in 2025.
  • Business Quant data shows Gross Profit for ELAN at $589.0 million in Q4 2025, $607.0 million in Q3 2025, and $713.0 million in Q2 2025.